Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Münzel

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|November 17, 2006
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients]T F Münzel, F Post
Deutsche Medizinische Wochenschrift (1946)|August 23, 2003
[Etanercept]U Mühlhäuser, F Münzel, T Eschenhagen
Deutsche Medizinische Wochenschrift (1946)|November 1, 2002
[Montelukast]F Münzel, U Mühlhäuser, T Eschenhagen
MMW Fortschritte Der Medizin|December 6, 2001
[Emergencies in the practice. Hazards of "mix syringe"]F Münzel, T Eschenhagen, T Rau, et al.
Circulation Research|February 9, 2002
Tissue engineering of a differentiated cardiac muscle constructW-H Zimmermann, K Schneiderbanger, P Schubert, et al.
International Journal of Cardiology|July 29, 2008
Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosisAlexander V Khaw, Ralph Stephan von Bardeleben, Christina Strasser, et al.
Heart (British Cardiac Society)|December 6, 2012
MR-proANP and MR-proADM for risk stratification of patients with acute chest painStergios Tzikas, Till Keller, Francisco M Ojeda, et al.
The American Journal of Cardiology|April 13, 2011
Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study)Christoph Sinning, Philip S Wild, Francisco M Ojeda Echevarria, et al.
European Heart Journal|February 12, 2008
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene studyRenate Schnabel, Claudia M Messow, Edith Lubos, et al.
European Heart Journal|January 21, 2009
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene studyTill Keller, Claudia Martina Messow, Edith Lubos, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|November 17, 2006
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients]T F Münzel, F Post
Deutsche Medizinische Wochenschrift (1946)|August 23, 2003
[Etanercept]U Mühlhäuser, F Münzel, T Eschenhagen
Deutsche Medizinische Wochenschrift (1946)|November 1, 2002
[Montelukast]F Münzel, U Mühlhäuser, T Eschenhagen
MMW Fortschritte Der Medizin|December 6, 2001
[Emergencies in the practice. Hazards of "mix syringe"]F Münzel, T Eschenhagen, T Rau, et al.
Circulation Research|February 9, 2002
Tissue engineering of a differentiated cardiac muscle constructW-H Zimmermann, K Schneiderbanger, P Schubert, et al.
International Journal of Cardiology|July 29, 2008
Direct measurement of left ventricular outflow tract by transthoracic real-time 3D-echocardiography increases accuracy in assessment of aortic valve stenosisAlexander V Khaw, Ralph Stephan von Bardeleben, Christina Strasser, et al.
Heart (British Cardiac Society)|December 6, 2012
MR-proANP and MR-proADM for risk stratification of patients with acute chest painStergios Tzikas, Till Keller, Francisco M Ojeda, et al.
The American Journal of Cardiology|April 13, 2011
Sex differences in early carotid atherosclerosis (from the community-based Gutenberg-Heart Study)Christoph Sinning, Philip S Wild, Francisco M Ojeda Echevarria, et al.
European Heart Journal|February 12, 2008
Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene studyRenate Schnabel, Claudia M Messow, Edith Lubos, et al.
European Heart Journal|January 21, 2009
Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene studyTill Keller, Claudia Martina Messow, Edith Lubos, et al.
Pageof 2